Variant report

Variant	esv3389348
Chromosome Location	chr1:212605479-212607477
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr1:212606688-212606888	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCLAF1	chr1:212605925-212606326	GM12878	blood:	n/a	chr1:212606242-212606255
3	BHLHE40	chr1:212605658-212606293	K562	blood:	n/a	n/a
4	CBX3	chr1:212605512-212606312	K562	blood:	n/a	n/a
5	CCNT2	chr1:212605784-212606756	K562	blood:	n/a	n/a
6	CEBPD	chr1:212606044-212606405	HepG2	liver:	n/a	n/a
7	CEBPD	chr1:212606098-212606490	HepG2	liver:	n/a	n/a
8	CHD1	chr1:212606701-212606742	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr1:212606018-212606362	Hela-S3	cervix:	n/a	chr1:212606199-212606209
10	CHD2	chr1:212605812-212606371	K562	blood:	n/a	chr1:212606199-212606209
11	CHD2	chr1:212606783-212606907	GM12878	blood:	n/a	n/a
12	CHD2	chr1:212605820-212606352	GM12878	blood:	n/a	chr1:212606199-212606209
13	CHD2	chr1:212606666-212606852	Hela-S3	cervix:	n/a	n/a
14	CHD2	chr1:212606111-212606235	HepG2	liver:	n/a	chr1:212606199-212606209
15	CREB1	chr1:212606043-212606516	A549	lung:	n/a	n/a
16	CTBP2	chr1:212606030-212606831	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr1:212606800-212606950	HEK293	kidney:	n/a	n/a
18	CTCF	chr1:212607080-212607230	HAc	cerebellar:	n/a	n/a
19	CTCF	chr1:212606880-212607030	AoAF	blood vessel:	n/a	n/a
20	CTCF	chr1:212606000-212606150	BJ	skin:	n/a	n/a
21	CTCF	chr1:212605980-212606130	K562	blood:	n/a	n/a
22	CTCF	chr1:212607040-212607190	A549	lung:	n/a	n/a
23	CTCF	chr1:212606042-212606118	Lung_OC	lung:	n/a	n/a
24	CTCF	chr1:212606080-212606230	GM12873	blood:	n/a	n/a
25	CTCF	chr1:212606320-212606470	AG04449	skin:	n/a	n/a
26	CTCF	chr1:212606840-212606990	GM12873	blood:	n/a	n/a
27	CTCF	chr1:212606900-212607050	HBMEC	blood vessel:	n/a	n/a
28	CTCF	chr1:212606020-212606170	AG04449	skin:	n/a	n/a
29	CTCF	chr1:212606360-212606510	HRE	kidney:	n/a	n/a
30	CTCF	chr1:212606100-212606250	GM12867	blood:	n/a	n/a
31	CTCF	chr1:212606340-212606490	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr1:212606221-212606226	Spleen_OC	spleen:	n/a	n/a
33	CTCF	chr1:212607180-212607330	BJ	skin:	n/a	n/a
34	CTCF	chr1:212605980-212606130	AoAF	blood vessel:	n/a	n/a
35	CTCF	chr1:212606780-212606930	K562	blood:	n/a	n/a
36	CTCFL	chr1:212607091-212607248	K562	blood:	n/a	n/a
37	E2F1	chr1:212606001-212606683	Hela-S3	cervix:	n/a	chr1:212606197-212606212 chr1:212606242-212606251
38	E2F4	chr1:212605969-212606788	K562	blood:	n/a	chr1:212606197-212606212 chr1:212606149-212606160 chr1:212606242-212606251
39	E2F4	chr1:212605923-212606247	GM12878	blood:	n/a	chr1:212606197-212606212 chr1:212606149-212606160
40	E2F4	chr1:212605863-212606363	MCF10A-Er-Src	breast:	n/a	chr1:212606197-212606212 chr1:212606149-212606160 chr1:212606242-212606251
41	E2F6	chr1:212605967-212606371	K562	blood:	n/a	chr1:212606197-212606212 chr1:212606158-212606169 chr1:212606242-212606251
42	E2F6	chr1:212606364-212606655	K562	blood:	n/a	n/a
43	E2F6	chr1:212605774-212606707	K562	blood:	n/a	chr1:212606197-212606212 chr1:212606158-212606169 chr1:212606242-212606251
44	E2F6	chr1:212606004-212606359	K562	blood:	n/a	chr1:212606197-212606212 chr1:212606158-212606169 chr1:212606242-212606251
45	EBF1	chr1:212605982-212606136	GM12878	blood:	n/a	n/a
46	EBF1	chr1:212606134-212606533	GM12878	blood:	n/a	n/a
47	EGR1	chr1:212606693-212606854	GM12878	blood:	n/a	chr1:212606806-212606828
48	EGR1	chr1:212606668-212607266	K562	blood:	n/a	chr1:212606806-212606828 chr1:212607090-212607101 chr1:212607086-212607100 chr1:212607090-212607100 chr1:212607088-212607102 chr1:212607090-212607100 chr1:212607089-212607102 chr1:212607088-212607103 chr1:212607089-212607102 chr1:212607100-212607111
49	EGR1	chr1:212605634-212605776	GM12878	blood:	n/a	chr1:212605675-212605689 chr1:212605699-212605713
50	EGR1	chr1:212605529-212605865	K562	blood:	n/a	chr1:212605675-212605689 chr1:212605699-212605713

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:212606819-212606869	GM12891	blood:	n/a
2	chr1:212606819-212606869	HPAEpiC	pulmonary alveolar:	n/a
3	chr1:212607111-212607161	CMK	blood:	n/a
4	chr1:212606756-212606806	GM12891	blood:	n/a
5	chr1:212605702-212605752	K562	blood:	n/a
6	chr1:212605702-212605752	HNPCEpiC	eye:	n/a
7	chr1:212606106-212606156	HepG2	liver:	n/a
8	chr1:212605929-212605979	Jurkat	blood:	n/a
9	chr1:212606819-212606869	Hepatocyte	liver:	n/a
10	chr1:212605929-212605979	HCM	heart:	n/a
11	chr1:212607111-212607161	A549	lung:	n/a
12	chr1:212607111-212607161	LNCaP	prostate:	n/a
13	chr1:212606106-212606156	GM12892	blood:	n/a
14	chr1:212605702-212605752	AG09309	skin:	n/a
15	chr1:212606756-212606806	BJ	skin:	n/a
16	chr1:212606756-212606806	AG04449	skin:	fetal
17	chr1:212606106-212606156	GM06990	blood:	n/a
18	chr1:212606106-212606156	T-47D	breast:	n/a
19	chr1:212605929-212605979	SKMC	muscle:	n/a
20	chr1:212606106-212606156	BJ	skin:	n/a
21	chr1:212606106-212606156	AG09309	skin:	n/a
22	chr1:212605702-212605752	NHDF-neo	bronchial:	n/a
23	chr1:212605702-212605752	GM06990	blood:	n/a
24	chr1:212605929-212605979	HNPCEpiC	eye:	n/a
25	chr1:212605929-212605979	U87	brain:	n/a
26	chr1:212605702-212605752	NH-A	brain:	n/a
27	chr1:212607111-212607161	HMEC	breast:	n/a
28	chr1:212606106-212606156	HL-60	blood:	n/a
29	chr1:212606756-212606806	HCM	heart:	n/a
30	chr1:212606106-212606156	SK-N-MC	brain:	n/a
31	chr1:212607111-212607161	IMR90	lung:	fetal
32	chr1:212606106-212606156	HRE	kidney:	n/a
33	chr1:212606756-212606806	GM06990	blood:	n/a
34	chr1:212606106-212606156	U87	brain:	n/a
35	chr1:212605929-212605979	GM12891	blood:	n/a
36	chr1:212606819-212606869	HMEC	breast:	n/a
37	chr1:212605929-212605979	PFSK-1	brain:	n/a
38	chr1:212605929-212605979	HCT-116	colon:	n/a
39	chr1:212605929-212605979	HCF	heart:	n/a
40	chr1:212605702-212605752	H1-hESC	embryonic stem cell:	embryo
41	chr1:212607111-212607161	RPTEC	kidney:	n/a
42	chr1:212606756-212606806	PrEC	prostate:	n/a
43	chr1:212606756-212606806	SK-N-SH	brain:	n/a
44	chr1:212607111-212607161	HCT-116	colon:	n/a
45	chr1:212606819-212606869	HCPEpiC	choroid plexus:	n/a
46	chr1:212607111-212607161	HAEpiC	amniotic membrane:	n/a
47	chr1:212605702-212605752	NT2-D1	testis:	n/a
48	chr1:212605702-212605752	HAEpiC	amniotic membrane:	n/a
49	chr1:212605929-212605979	Caco-2	colon:	n/a
50	chr1:212605702-212605752	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr1:212607004..212608669-chr1:212617399..212619627,2	MCF-7	breast:
2	chr1:212606882..212608476-chr1:212631103..212632696,2	MCF-7	breast:
3	chr1:212586060..212592297-chr1:212603893..212609565,9	MCF-7	breast:
4	chr1:212601837..212604261-chr1:212607082..212608866,2	K562	blood:
5	chr1:212587912..212590110-chr1:212604889..212609190,4	K562	blood:
6	chr1:212606631..212609505-chr1:212609658..212612237,5	K562	blood:
7	chr1:212591382..212593654-chr1:212604322..212606198,2	K562	blood:
8	chr1:212596755..212599311-chr1:212603910..212605843,2	MCF-7	breast:
9	chr1:212606338..212608364-chr1:212730714..212733205,2	K562	blood:
10	chr1:212585974..212594847-chr1:212598812..212609579,19	K562	blood:
11	chr1:212541839..212544001-chr1:212606359..212607860,2	MCF-7	breast:
12	chr1:212604504..212608752-chr1:212780786..212783858,6	K562	blood:
13	chr1:212598606..212601343-chr1:212603803..212606120,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM206-1	chr1:212605967-212606095	XLOC_001192

Variant related genes	Relation type
NENF	TF binding region
NENF	CpG island
ENSG00000162772	chromatin interactions
ENSG00000260805	chromatin interactions
ENSG00000065600	chromatin interactions
COL1A1	miRNA target sites

Extended variants
information (count: 66 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:66 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs574383863	chr1:212605494-212605495	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs485730	chr1:212605528-212605529	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs116259559	chr1:212605543-212605544	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs527570798	chr1:212605547-212605548	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs144951281	chr1:212605618-212605619	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs556092605	chr1:212605627-212605628	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs563890807	chr1:212605647-212605648	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs532658681	chr1:212605657-212605658	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs550760874	chr1:212605703-212605704	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs569316659	chr1:212605714-212605715	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs181812637	chr1:212605719-212605720	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs149049723	chr1:212605753-212605754	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs567183746	chr1:212605843-212605844	Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs534449676	chr1:212605871-212605872	Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs74138154	chr1:212605938-212605939	Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs185208172	chr1:212605943-212605944	Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs538419273	chr1:212605955-212605956	Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs533820107	chr1:212606007-212606008	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
19	rs574471465	chr1:212606022-212606023	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
20	rs541463978	chr1:212606092-212606093	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
21	rs559676941	chr1:212606107-212606108	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs572010663	chr1:212606117-212606118	Bivalent/Poised TSS Active TSS Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs545662229	chr1:212606234-212606235	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs371873789	chr1:212606245-212606246	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs56061261	chr1:212606261-212606262	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs189684897	chr1:212606266-212606267	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs531437747	chr1:212606271-212606272	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs549948690	chr1:212606285-212606286	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs562883534	chr1:212606287-212606288	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs11542945	chr1:212606352-212606353	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs530171448	chr1:212606418-212606419	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs548607474	chr1:212606424-212606425	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs75793592	chr1:212606458-212606459	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs566844780	chr1:212606489-212606490	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs375223689	chr1:212606599-212606600	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs74636338	chr1:212606678-212606679	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs552938481	chr1:212606709-212606710	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs3754144	chr1:212606744-212606745	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs538102710	chr1:212606791-212606792	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs556707513	chr1:212606794-212606795	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs181356232	chr1:212606926-212606927	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs371050124	chr1:212606994-212606995	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs114534742	chr1:212607007-212607008	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs571671424	chr1:212607024-212607025	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs371748418	chr1:212607043-212607044	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs545375809	chr1:212607056-212607057	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs557793143	chr1:212607065-212607066	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs576279617	chr1:212607066-212607067	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs375612120	chr1:212607078-212607079	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs368736747	chr1:212607086-212607087	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Trisomy 5 syndrome	21098271	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
Multiple myeloma	16461302	CNVD
van der Woude syndrome	22470819	CNVD
van der Woude syndrome	20818247	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	17060936	CNVD
Atypical hemolytic uremic syndrome	19861685	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Medulloblastoma	16783165	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Holoprosencephaly	19184110	CNVD
Breast cancer	21069454	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:494 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:212591000-212605600	Weak transcription	Brain Inferior Temporal Lobe	brain
2	chr1:212598400-212605600	Weak transcription	Brain Substantia Nigra	brain
3	chr1:212598800-212605600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr1:212602800-212605600	Weak transcription	Cortex derived primary cultured neurospheres	brain
5	chr1:212603400-212605600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr1:212603400-212606000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr1:212603800-212605600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr1:212603800-212605800	Enhancers	Fetal Intestine Large	intestine
9	chr1:212604000-212605600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr1:212604000-212605600	Weak transcription	Fetal Heart	heart
11	chr1:212604000-212605800	Enhancers	Fetal Intestine Small	intestine
12	chr1:212604200-212605600	Weak transcription	Brain Angular Gyrus	brain
13	chr1:212604200-212605600	Enhancers	HepG2	liver
14	chr1:212604200-212605800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
15	chr1:212604400-212605600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr1:212604400-212605600	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr1:212604400-212605600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr1:212604400-212605600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr1:212604400-212605600	Weak transcription	NHDF-Ad	bronchial
20	chr1:212604400-212605800	Weak transcription	Fetal Stomach	stomach
21	chr1:212604400-212605800	Enhancers	HUVEC	blood vessel
22	chr1:212604400-212606000	Enhancers	Small Intestine	intestine
23	chr1:212604600-212605600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr1:212604600-212605600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
25	chr1:212604600-212605600	Enhancers	Duodenum Mucosa	Duodenum
26	chr1:212604600-212605600	Enhancers	GM12878-XiMat	blood
27	chr1:212604600-212605800	Enhancers	Stomach Mucosa	stomach
28	chr1:212604600-212606400	Enhancers	Placenta Amnion	Placenta Amnion
29	chr1:212604800-212605600	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr1:212604800-212605600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
31	chr1:212604800-212605600	Enhancers	Primary hematopoietic stem cells short term culture	blood
32	chr1:212604800-212605600	Enhancers	Brain Anterior Caudate	brain
33	chr1:212604800-212605600	Enhancers	Brain Cingulate Gyrus	brain
34	chr1:212604800-212605600	Enhancers	Rectal Mucosa Donor 29	rectum
35	chr1:212604800-212605800	Weak transcription	Primary T cells from cord blood	blood
36	chr1:212604800-212605800	Enhancers	Primary hematopoietic stem cells	blood
37	chr1:212604800-212605800	Enhancers	Fetal Muscle Leg	muscle
38	chr1:212604800-212605800	Enhancers	Placenta	Placenta
39	chr1:212605000-212605600	Enhancers	H1 Cell Line	embryonic stem cell
40	chr1:212605000-212605600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
41	chr1:212605000-212605600	Enhancers	Breast Myoepithelial Primary Cells	Breast
42	chr1:212605000-212605600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr1:212605000-212605600	Weak transcription	Brain Hippocampus Middle	brain
44	chr1:212605000-212605600	Enhancers	Colonic Mucosa	Colon
45	chr1:212605000-212605600	Enhancers	Left Ventricle	heart
46	chr1:212605000-212605600	Enhancers	Rectal Mucosa Donor 31	rectum
47	chr1:212605000-212605600	Enhancers	Right Atrium	heart
48	chr1:212605000-212605600	Enhancers	Right Ventricle	heart
49	chr1:212605000-212605600	Enhancers	K562	blood
50	chr1:212605000-212605800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links